Incidence of hyperkalaemia and major creatinine elevation after renin–angiotensin system inhibitor initiation in a Singapore primary care cohort

Abstract Background Renin–angiotensin system inhibitors (RASis), including ACE inhibitors (ACEis) and angiotensin receptor blockers (ARBs), are commonly initiated in primary care for various clinical indications. However, the risk of hyperkalaemia and increased serum creatinine levels after initiati...

Повний опис

Бібліографічні деталі

Автори:	Michael Warren Lim, Anna Szücs, Desmond Ong, Stephanie C. C. Van Der Lubbe
Формат:	Artigo
Мова:	Inglês
Опубліковано:	BMC 2026-02-01
Серія:	BMC Primary Care
Предмети:	Renin-angiotensin system inhibitor Hyperkalaemia Adverse effect Primary care Asian population
Онлайн доступ:	https://doi.org/10.1186/s12875-026-03195-8
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!